Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Loading ETF research
Fetching the latest fund profile, holdings, and market data.
NASDAQEquity ETF
$24.6647
+$0.3047 · +1.25%
At close: Nov 3, 4:00 PM ET
Regular session · ET · Market data may be delayed.
T. Rowe Price Biotech ETF is an actively managed exchange-traded fund that seeks long-term capital appreciation by investing primarily in biotechnology and life sciences companies. The fund focuses on companies developing innovative therapies, medicines, and technologies across areas such as biotechnology, pharmaceuticals, and medical research. T. Rowe Price lists the fund under the ticker TDNA.
Fund facts updated Nov 3, 2026.
Day range
Current $24.6647
52-week range
Current $24.6647
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
1 month
+0.39%
Since inception
-3.24%
Cumulative price changes exclude distributions and investor-specific taxes, trading costs, and cash flows.
Showing 15 of 88 reported holdings
Displayed portfolio weight: 38.69%
Holdings data updated Nov 4, 2026.
VXUS
Vanguard Total International Stock ETF
$82.25
-0.41%
QQQ
Invesco QQQ Trust, Series 1
$685.28
+0.62%
BMOP
BNY Mellon Municipal Opportunities ETF
$24.0149
+0.05%
BND
Vanguard Total Bond Market ETF
$71.20
-0.18%
BNDX
Vanguard Total International Bond ETF
$47.29
-0.13%
GRAG
Leverage Shares 2x Long GRAB Daily ETF
$4.24
+17.45%
